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Abstract
Purpose of the Review Pathways for obesity prevention and treatment are well documented, yet the prevalence of obesity is
rising, and access to treatment (including bariatric surgery) is limited. This review seeks to assess the current integrated clinical
pathway for obesity management in England and determine the major challenges.
Recent Findings Evidence for tier 2 (community-based lifestyle intervention) and tier 3 (specialist weight management services)
is limited, and how it facilitates care and improve outcomes in tier 4 remains uncertain. Treatment access, rigidity in pathways,
uncertain treatment outcomes and weight stigma seems to be major barriers to improved care.
Summary More emphasis must be placed on access to effective treatments, treatment flexibility, addressing stigma and ensuring
treatment efficacy including long-term health outcomes. Prevention and treatment should both receive significant focus though
should be considered to be largely separate pathways. A simplified system for weight management is needed to allow flexibility
and the delivery of personalized care including post-bariatric surgery care for those who need it.
Keywords Obesity management . Obesity . NHS . Clinical pathways . Tier 3 . Tier 2 . Tier 4 . Weight management . Medical
management . Integrated pathway
Introduction
Obesity is a global public health priority. Preventing and
treating obesity represents a significant opportunity to im-
prove people’s quality of life and the health of society and
reduce the financial pressures on the National Health Service
(NHS). Obesity prevalence in England has increased from
14.9% in 1993 to 26.9% in 2015 [1], and it is projected that
an additional 11 million people will be living with obesity in
the UK by 2050 [2]. In 2015 the NHS spent £6.1 billion on
overweight- and obesity-related ill health, and the cost of obe-
sity to the wider society was estimated to be £37 billion [1].
The cost is projected to increase to just under £50 billion in
2050 if obesity rates rise as predicted [3]. Therefore, it is no
surprise that the NHS, Public Health England and the wider
healthcare system are highly interested in both the prevention
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and treatment of obesity though this has not translated into
clear and effective pathways for either prevention or
treatment.
In 2011, the Department of Health published a policy paper
“Healthy Lives, Healthy People: A Call to Action on Obesity
in England”, which sets a target to reduce the prevalence of
obesity in adults by 2020 by providing strategies for the pre-
vention and treatment of obesity [4]. Despite this, the preva-
lence of obesity has continued to increase, yet the provision of
weight management services and obesity treatment in the UK
remains variable geographically and relatively limited in com-
parison to other European countries, most of which have low-
er prevalence of obesity [5–7]. It appears that the approaches
taken to date have not been effective in treating many patients
with obesity. In addition, this is also despite multiple docu-
ments and policies being issued by the National Institute for
Health and Care Excellence (NICE) (clinical guidelines 43
and 189; quality standards 127; public health guidelines 42,
46, 47 and 53 [8–15]; from Public Health England (Health
matters: obesity and the food environment, Joined up clinical
pathways for obesity) and NHS England (Five Year Forward
View, Healthy Lives, Healthy People: A Call to Action on
Obesity in England), amongst others [1, 16].
Therefore, for the reasons listed above, it is our view that
the NHS did not get the integrated pathway for weight man-
agement right. However, that does not mean that there are not
positive elements within the system. To justify this opinion,
we will describe the current weight management tiered sys-
tem, its origins and purpose and assess its outcomes. We will
also describe the challenges faced by the integrated clinical
pathways.
The Integrated Clinical Pathways
for the Management of People with Severe
Obesity: Structure and Purpose
Within the NHS in England, current obesity management is
delivered through a tiered system [17] (Table 1). In 2006,
NICE Clinical Guidance (CG) 43 recommended that people
with severe obesity should be treated in a specialist setting that
has the necessary infrastructure (including equipment) and
expertise [12]. NICECG 43 also recommended that the shared
decision-making process between the clinical team and the
patient should be adopted and that the treatment plan should
be personalized and adapted to the person’s preferences, initial
fitness, health status and lifestyle [12]. Seven years later, in
2013, the Action on Obesity report from the Royal College of
Physicians concluded that the multidisciplinary services nec-
essary to manage patients with obesity and its complications
were poorly developed within the UK and that the response of
the NHS to obesity was highly variable [18]. In 2014, the
Department of Health Working Group report on the joined
up clinical pathways for obesity described the 4 tiers
(Fig. 1). Tier 1 is a universal intervention aimed at prevention
and re-enforcement of healthy lifestyle principles. Tier 2 is
lifestyle and weight management services that can include
commercial weight management providers, and it is often time
limited to 12 weeks and typically consists of group sessions
covering diet, physical activity and behavioural change. Tier 3
is clinician-led weight management services that consist of a
multidisciplinary team (MDT) including specialist dietitians,
nurses, psychologists and physiotherapists that could be de-
livered in either primary or secondary care. Tier 4 is bariatric
surgery with MDT support pre- and post-surgery (Table 1)
[16].
However, the Department of Health also stated that “…
these definitions represent the considered views of the major-
ity of the group at the time and were used as a reference to
understand the context of Tier 3 and 4. They are provided for
information rather than as a definition” [16]. In addition, the
definitions regarding which patient population should receive
which tier of care lack clarity. Taken together, it is therefore
unsurprising that provision of weight management services
remains inconsistent and there is heterogeneity in provision.
However, NICE has provided clear guidance and recommen-
dations on when to consider referral to tier 3 services [14],
which include the following:
1. The underlying causes of living with overweight or obe-
sity need to be assessed.
2. The person has complex disease states or needs that can-
not be managed adequately in tier 2 (e.g. the additional
support needs of people with learning disabilities).
3. Conventional treatment has been unsuccessful.
4. Drug treatment is being considered for a person with a
body mass index (BMI) of more than 50 kg/m2.
5. Specialist interventions (such as a very-low-calorie diet)
may be needed.
6. Bariatric surgery is being considered.
In addition, NICE CG 189 recommended that bariatric sur-
gery should be considered if the patient fulfils all of the fol-
lowing criteria:
1. BMI of 40 kg/m2 or more, or between 35 and 40 kg/m2
and other significant disease (e.g. type 2 diabetes or high
blood pressure) that could be improved with weight loss.
2. All appropriate non-surgical measures have been tried,
but the person has not achieved or maintained adequate,
clinically beneficial weight loss.
3. The person has been receiving or will receive intensive
management in a tier 3 service.
4. The person is generally fit for anaesthesia and surgery.
5. The person commits to the need for long-term follow-up.
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NICE CG 189 also stated that bariatric surgery is the treat-
ment of choice for adults with a BMI ≥ 50 kg/m2 when other
interventions have not been effective and that surgery should
be performed by an experienced surgeon in specialist centres
with access to a multidisciplinary team [12]. Patient selection
processes should ensure that only those patients who stand to
benefit the most from surgery are referred. This policy man-
dated that patients should have received and complied with a
tier 3 weight management service for 12–24 months prior to
referral to bariatric surgery except for patients with BMI >
50 kg/m2 where 6 months in tier 3 were deemed adequate.
This commissioning policy defined theMDT in tier 3 to be led
by a professional with a specialist interest in obesity and
should include a physician, specialist dietitian, nurse, psychol-
ogist and physical exercise therapist, all of whom must also
have a specialist interest in obesity [17]. The role of the MDT
before considering bariatric surgery was defined as “assess-
ment of evidence that all suitable non-invasive options have
been explored and trialled and individualised patient focus
and targets”, to provide education regarding diet and physical
activity, exclude underlying endocrine conditions and evalu-
ate and manage comorbidities and psychological factors rele-
vant to obesity. In addition, the policy stated that tier 3 should
evaluate patients’ engagement in non-surgical tier 3/4 ser-
vices. It was suggested that “Engagement can be judged by
attendance records and achievement of pre-set individualised
targets, for example steady and sustained weight loss of 5-
10% or maintaining constant weight whilst stopping
smoking” [17]. The policy was recommended referring for
bariatric surgery patients who have been unable to lose clini-
cally significant weight (i.e. enough to modify comorbidities)
during the period of intervention.
Overall, based on these guidelines, the main objectives of
tier 3 weight management services have been to achieve clin-
ically meaningful weight loss in patients with obesity-
associated comorbidities in those not considering surgery. In
those who want (and are eligible for) bariatric surgery, tier 3
would ensure that all other treatment options have been tried
and failed and “select” those who are likely to do better after
surgery with suggested ways of patient selection through at-
tendance to tier 3 and achievement of 5–10% weight loss,
although pre-surgery weight loss is not a funding requirement
for bariatric surgery.
So below we consider the evidence whether tiers 2 and 3
can deliver and are delivering these recommended roles.
Tier 2 Weight Management Services: What Is
the Evidence?
Tier 2 weight management services, which are community
based, have been shown to be effective in the case of utilizing
commercial weight management programmes. Referral from
primary care to commercial weight management programmes
resulted in a modest, but significant weight loss compared to
the standard care over a 12-month period in a multinational
RCT [− 5.06 kg (SE 0.31) vs. − 2.25 kg (0.21), adjusted dif-
ference – 2.77 kg, 95% CI − 3.50 to − 2.03] with the last
observation carried forward; but the trial had a high dropout
rate of 55% [20]. In another RCT primary care, physicians
randomly assigned participants to one of two 30-s interven-
tions: advice regarding weight loss vs. referral to a weight
management group (12 sessions of 1 h each, once per week).
The adjusted difference in weight loss was 1.43 kg (95% CI
Fig. 1 The tiered weight management system in England. Adapted from Wilding 2018 [19]
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0.89–1.97) in favour of the referral intervention [21]. Overall,
these programmes result in a modest but meaningful weight
loss at 12months (around 2.2–5 kg on average), and they were
superior to general practice or pharmacy-led 1-2-1 counselling
[22–25]. In addition, these programmes have been shown to
have modest effects on other health outcomes such as
glycaemic control, blood pressure and lipids [26, 27].
Tier 3 Weight Management Services: What Is
the Evidence?
Outcomes of Tier 3 Weight Management Services in
England
A clinically meaningful weight loss was defined by NICE as
5–10% as there is evidence that this amount of weight loss can
have a favourable impact on obesity comorbidities, although it
is acknowledged that a higher percentage weight loss may be
needed in people with BMI ≥ 35 kg/m2 [28]. There are limited
data on the outcomes of tier 3 services in England, such as
weight loss and improvements in health, comorbidities and
quality of life. Furthermore, there are currently no published
data on long-term outcomes following discharge from tier 3.
Below is a summary of the studies to date that have assessed
weight loss and health outcomes, as well as retention rates in
English tier 3 weight management services. Some of these
studies are only available as abstracts and therefore have only
reported limited data. The available data regarding English tier
3 are spread between community-based [29–32] and second-
ary care-based services [33–36]. Follow-up duration was be-
tween 6 and 24 months. Percentage of participants losing ≥
5% weight loss on completion of the program varied signifi-
cantly ranging from 22% [35] to > 70% [30, 36]. The attrition
rate varied significantly and was not necessary a feature of
follow-up duration [29, 35] (Table 2).
In a systematic review tier 3 or UK pre-bariatric weight
management services, which included low energy diets,
43.4% and 29.4% achieved ≥ 5% and 10%weight loss respec-
tively [38]. This was associated with improved metabolic
health outcomes, but the studies were overall of poor quality
with high risk of bias [38]. In another more recent systematic
review that examined 20 studies including low energy diets
(LED) and studies in tiers 2 and 3 weight management as well
as studies from before, the tiered system showed high drop-
outs with modest weight losses in the studies not using LED
[39]. Another systematic review of 14 studies of multicompo-
nent interventions in the UK or Ireland (including LED and
VLED) showed weight losses between 2.2 and 12.4 kg [40].
But when the VLED and LED were excluded, the weight loss
was modest between 2 and 6 kg. The dropouts were high (43–
62%), and achievement of ≥ 5% weight loss amongst com-
pleters ranged from 32 to 51% [40].
The above-described results of tier 3 services are consistent
with what can be achieved with lifestyle interventions. In a
meta-analysis of 32 RCTs that compared weight management
programmes to routine care or active control, the weighted
mean difference (95%CI) of weight loss between the interven-
tion and the control groups was − 3.75 (− 5.17 to − 2.33) kg
and − 2.99 (− 4.64 to − 1.35) kg at 12 and 24 months respec-
tively [41]. The same study found that weight management
programmes were cost-effective [41]. The NICE public health
guideline PH53 in 2014 considered 29 randomized controlled
trials of lifestyle weight management programmes lasting
12 months or longer; 7 reported outcomes at ≥ 3 years, and
none reported outcomes beyond 5 years [9]. The guideline
stated that “Modelling showed that even a small amount of
weight loss is cost effective, but only if it is maintained long
term” [9].
In summary, the current data regarding the efficacy of tier 3
weight management services is limited. From the available
data, it seems that these services are supporting patients to
Table 2 Summary of the available tier 3 data in England
Reference Location Sample size Follow-up (months) % losing ≥ 5% who
completed follow-up
% lost to the service
by the end of follow-up
Senior 2013 [36] Rotherham 3325 6 72 51
Jennings 2014 [30] Fakenham 828 12 72 46
Wright 2015 [29] Birmingham community 144 12 22 (lost > 10%) 10
Brown 2015 [33] Birmingham secondary 828 6 32 44
Hughes 2015 [31] Fakenham 213 12 60 26
Kininmonth 2016 [34] Wakefield 280 6 16* 32
Nield 2016 [32] Sheffield 288 6 30 60
Steele 2017 [37] Liverpool 1249 24 24.1 60
Fountain 2019 [35] Derby 430 6 22 78
*Intention to treat analysis available rather than data relating to those who had completed the program
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achieve modest 5% weight loss in 50% of patients over 6–
12 months, but this varies between services. In addition, the
tier 3 services support about 20–25% of patients to achieve ≥
10% weight loss. However, there are no data reporting on the
sustainability of weight loss or associated health benefits on
the long term. This is particularly pertinent given that 80% of
patients who lose 5% body weight will regain it over 5 years
[42]. In addition, although the retention rates varied consider-
ably in the published data, most were below 55%. Low reten-
tion rates, modest weight loss and the lack of long-term data
make the cost-effectiveness of tier 3 weight management ser-
vices uncertain and requiring evaluation. Evaluating the cost-
effectiveness of tier 3 services is likely to be challenging given
significant variation in the structure of each tier 3 service.
Selection for Bariatric Surgery
In those who want to have bariatric surgery, roles and func-
tions of the MDT have already been outlined above regarding
what is expected from tier 3. We will now address the evi-
dence for these below.
Achieving Weight Loss to Reduce the Number of People
Pursuing Bariatric Surgery
Patients interested in undergoing bariatric surgery want to
attain 38% weight loss on average and would be disappointed
if they did not lose 26% [43], so the modest 5% weight loss
typically seen in tier 3 is not likely to affect patients’ desire to
pursue surgical treatment. In addition, to weight loss, patients
expect major psychological and physical improvement after
surgery [44]. Hence, it is unlikely that tier 3 services will have
a significant impact on reducing the need for bariatric surgery
considering the modest weight loss and the lack of evidence
regarding major improvement in physical and mental do-
mains. In those losing > 10% weight in tier 3, there is limited
evidence about maintenance and long-term health outcomes.
This needs to be considered within the evidence showing that
most weight loss via non-pharmacological and non-surgical
interventions is regained over variable amount of time [42, 45,
46]. A reduction in the number of those pursuing surgery may
occur given potential new pharmacotherapy options resulting
in 15–25% weight loss over 12 months. However, until then,
data are lacking regarding the ability of tier 3 services to re-
duce referral for bariatric surgery.
Selecting the Right Patient: Motivation and Engagement
The concept that motivation is important for selecting patients
for bariatric surgery is arguable given that bariatric surgery,
especially Roux-en-Y gastric bypass and sleeve gastrectomy,
results in significant weight loss, weight loss maintenance and
metabolic improvement via multiple complex neurohormonal
mechanisms rather than simply dietary restriction [47, 48].
Furthermore, bariatric surgery has been shown to work in
animals, whice have no apparent motivation for weight loss
[49].
In a study by Dixon et al., the readiness to change (RTC)
was measured using the University of Rhode Island Change
Assessment in 227 consecutive patients undergoing adjustable
gastric banding surgery [50]. The RTC scores were blinded
until study completion. There was no significant correlation
between RTC score and percentage excess weight loss over
2 years (r = 0.047, p = 0.5). There was no difference in per-
centage (%) excess weight loss at 2 years between those under
and over the median RTC score [52.9 ± 26.9% vs. 52.2 ±
28.3%, p = 0.869] [50]. There was no weight loss difference
between highest and lowest quartiles or a nonlinear relation-
ship between weight loss and RTC score, and there was no
significant relationship between RCT score and compliance
[50]. Furthermore, there was no difference in % excess weight
loss a t 2 years between those who were in the
precontemplation (53.8 ± 25.2%), ready to change (53.8 ±
23.6%) or ambivalent (50.8 ± 26.8) stages before surgery [50].
In another study of 64 patients (mean BMI 51 ± 8 kg/m2)
undergoing laparoscopic sleeve gastrectomy, % excess weight
loss over an average follow-up of 20 months was not corre-
lated with motivation [51]. In this study, motivation was
assessed using a motivation survey that was developed with
10 items asking how strongly patients were “self-motivated”
to lose weight or motivated by their “social environment” (i.e.
partner, family/children, friends, colleagues and employer) or
“treatment environment” (i.e. physician, health insurance, nu-
tritionist and therapist) [51]. Patients indicated their answers
on a 5-point scale that ranged from 1 = not at all to 5 = very
strong [51]. In another study, the weight loss 3 years post-
laparoscopic adjustable gastric banding was similar in public-
ly funded vs. self-funded patients (mean excess weight loss %
59.7 vs. 61.8%, p = 0.784, 50% excess weight loss achieved in
55.2 vs. 66.0%, p = 0.349), suggesting that motivation by self-
funding did not affect post-surgical weight loss [52].
Even in the context of medical weight management, the
Dieting Readiness Test (DRT) did not predict program atten-
dance or weight loss in 410 adults with obesity seeking weight
management in a tertiary centre [53].
Another important point is that maximum weight loss can
be predicted by early post-operative weight loss and the var-
iation in post-surgery weight loss follows a normal distribu-
tion which is similar to the treatment effects of surgical or non-
surgical interventions for conditions other than obesity [54].
This suggests that this is likely due to biological factors rather
than motivation.
Hence, there is currently no clinical evidence that motiva-
tion and engagement in before surgery either contribute to or
predict better weight loss outcomes after bariatric surgery.
However, whether it can predict outcomes other than weight
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loss or lower adverse events after surgery is currently un-
known. In addition, it must be noted that the results of the
studies such as the ones described above were dependent on
the methods of assessment of motivation or engagement. The
notion that motivation is important in predicting bariatric sur-
gery outcomes probably stems from obesity stigma the per-
ception that obesity is a “choice” rather than a chronic disease.
Selecting the Right Patient: Achieving 5–10% Weight Loss
before Surgery
Whether weight loss during medical weight management pre-
dicts post-bariatric surgery weight loss is controversial. In a
systematic review that was published in 2012, mandatory pre-
operative weight loss was associated with greater post-
surgical weight loss (over 3 to 48 months) in 6 studies, no
association in 7 studies and negative association in 1 study
(N from all studies 3254) [55]. Similar conflicting results were
shown in a more recent systematic review in 2014 [56]. In a
more recent study from 2018 that included 218 patients, pre-
operative weight loss duringmedical weight management was
not an independent predictor of weight loss at 12months post-
bariatric surgery [57]. In a study of 141 patients who
underwent laparoscopic sleeve gastrectomy, there was no cor-
relation between pre-op % BMI change and 12 months post-
surgery % BMI change and no differences in excess % BMI
loss between different amounts of % BMI change before sur-
gery [58].
In a study from Birmingham, UK, which does not mandate
weight loss in tier 3 before referring to surgery, and that in-
cluded 208 patients (LAGB n = 128, RYGB n = 80), 197 par-
ticipants (94.7%) and 183 participants (88.0%) attended
follow-up at 12 and 24 months respectively [59]. There was
no difference in post-operative weight loss at 12 or 24 months
between those with ≥ or < 5% weight loss during a tier 3
weight management services. Weight loss in tier 3 did not
predict weight loss at 12 or 24 months despite adjustment
for age, gender, ethnicity, baseline weight (kg), time in tier 3
and type 2 diabetes. In another study from Birmingham that
included 45 patients with type 2 diabetes, there was no signif-
icant relationship between the % weight loss induced by
glucagon-like peptide 1 (GLP-1) receptor agonists during tier
3 services and 12 months post-surgical (band, sleeve, bypass)
% weight loss [60]. Interestingly, the correlation coefficients
were negative (especially in the gastric bypass and sleeve
gastrectomy group) suggesting higher post-operative weight
loss in those with less weight loss following GLP-1 agonist
treatment [60].
Overall, there is no convincing evidence that weight loss
during medical weight management predicts post-operative
weight loss. Data specific to tier 3 services in that regard are
limited to the two studies described above, and the quality of
that evidence is limited by the observational nature of the
studies. However, based on the available data, achieving a
mandatory weight loss target in tier 3 as a pre-condition to
referral to bariatric surgery is not justified. It should also be
noted that bariatric surgery outcomes are not limited to weight
loss and whether mandatory weight loss in tier 3 can improve
other clinical and metabolic outcomes or quality of life is
currently unknown.
The above discussion regarding 5–10%weight loss in tier 3
should not be confused with the pre-operative weight loss
achieved by the “liver shrinking” diet (which varies between
LED, VLED and ketogenic diet) that has been shown to re-
duce liver volume before bariatric surgery and might have a
favourable impact on wound healing, hospital stay and post-
surgery complications [61–64].
Improving Post-Surgical Outcomes: Addressing Mental
Health and Eating Disorders
Mental health disorders, such as depression, anxiety, body
dysphoria, poor self-esteem and eating disorder, are very com-
mon in patients with obesity undergoing bariatric surgery
[65]. Bariatric surgery has also been reported to be associated
with increased risk of self-harm and suicide. In a systematic
review, the post-bariatric suicide event rate was 2.7/1000 pa-
tients (95% CI 0.0019–0.0038), and the suicide/self-harm at-
tempt event rate was 17/1000 patients (95% CI 0.01–0.03)
[66]. The self-harm/suicide attempt risk was higher after vs.
before bariatric surgery (OR 1.9 (95% CI 1.23–2.95)), and
when compared to age, gender and BMI matched control pop-
ulation (OR 3.8 (95% CI, 2.19–6.59)) [66]. The increased of
self-harm occurs following all bariatric procedures although
highest post-RYGB [67]. However, whether these mental
health disorders predict post-surgical weight loss is unclear,
and studies have shown conflicting results. For example, a
systematic review in 2012 found that three studies showed
positive associations, 13 studies showed neutral associations,
and four showed negative associations between binge eating
and post-operative weight loss [55]. Similarly, with regard to
emotional eating, three studies in this review showed neutral
associations, and three studies showed negative associations;
and in regard to binge eating, three studies reported that pa-
tients with pre-operative binge eating lost more weight post-
operatively than those without binge eating, thirteen studies
reported no association, and four studies reported a negative
association [55]. With regard to depression, one study showed
a positive association, fourteen studies showed neutral associ-
ations, and four studies showed negative associations, and
similar conflicting results were shown in regard to other psy-
chological disorders as well as history of sexual abuse [55].
The recent British Obesity and Metabolic Surgery Society
(BOMSS) guidelines regarding pre- and post-surgical psycho-
logical weight management also acknowledged the impor-
tance of providing post-surgical psychology support to
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patients with bariatric surgery [65]. Particularly that many
mental health and eating disorders may recur or occur de novo
post-surgery and that these conditions are associated with less
weight loss and adverse outcomes when they are present post
bariatric surgery [65]. In addition, it is widely accepted that it
is important to address significant mental health disease to
ensure that the patients are able to undergo surgery and make
informed choices. However, there appears to be a lack of
evidence to support or refute whether addressing mental
health disorders pre-surgery improve bariatric surgery out-
comes as bariatric surgery is consistently associated with
post-operative decreases in the prevalence and severity of de-
pression [68]. The delivery of high-quality psychological as-
sessments and treatments is rather challenging due to the lack
of enough psychologists. Hence, alternative strategies are
needed including upskilling other members of the multidisci-
plinary team to perform such duties under the supervision of a
clinical psychologist and the reliance on some of the mental
health services delivered in the community, although these are
not weight management specific.
Has the NHS in England Got It Right? Our View and the
Challenges Despite the modest efficacy of tier 2 services (de-
tailed above), there is still a lack of data on long-term out-
comes, and these programmes typically have high levels of
dropouts, and also cost-effectiveness can vary according to the
program [23, 69]. However, they are appropriate for a sub-
group of patients with overweight or obesity and applicable at
a population level where modest weight loss would be mean-
ingful. Nonetheless, these are not widely accessible. Many
areas in the UK do not have tier 2 services, and they have an
associated cost if privately funded, which is challenging con-
sidering that obesity prevalence is higher in people from dis-
advantaged socio-economic backgrounds which further in-
crease health inequalities.
Tier 3 services, within the current structure, are only acces-
sible for a sub-set of patients with obesity, i.e. those with
complex obesity. In patients not requiring or wanting bariatric
surgery, tier 3 seems to result in modest, but clinically signif-
icant weight loss over a 6–12-month period, although a 10%
weight loss which is more meaningful clinically is only
achieved in less than 20% of patients as described above.
However, the few studies reviewing tier 3 services generally
had methodological weaknesses, and cost-effectiveness is un-
clear due to high dropout rates, the lack of long-term data and
the variation in the structure of the programmes. Furthermore,
the evidence for impact of tier 3 on outcomes other than
weight is very limited, and there is a lack of data in regard to
hard outcomes such as mortality or cardiovascular disease. So,
in short, for this group of patients, tier 3 appears to be mod-
estly effective, but is it the best way to deliver these benefits?
Hence, the current approaches to tier 3 might need to be
revisited.
In the context of bariatric surgery, the current tier 3 is al-
most set up to fail most of its objectives particularly in terms of
“selecting” those who are likely to achieve greater weight loss
post-surgery and reducing the number of patients needing sur-
gery in a significant manner. It is virtually impossible for tier 3
services to be effective in “selecting” the best candidates for
bariatric surgery (in terms of weight loss achieved) due to the
lack of evidence to support this selection process and the lack
of reliable predictors of outcomes. As a result, whichever
criteria used to “select” patients by individual services have
become barriers between patients and surgery rather than de-
livering care and personalizing treatment approaches. In addi-
tion, considering the modest weight loss achieved in tier 3, its
ability to reduce the need for surgery is likely to be negligible
and is based on very simplistic assumptions that do not take
into account either the complexity of obesity or bariatric sur-
gery. In addition, it has been shown that patients undergoing
bariatric surgery can have unrealistic expectations in regard to
weight loss. Therefore, the modest weight loss likely to be
achieved in tier 3 will not be satisfactory to the patient inmany
cases [70].
However, tier 3 services still have an important role to play
in preparing patients for surgery in terms of education, man-
aging patient expectations, addressing and optimizing obesity-
related complications prior to surgery and helping patients to
make informed choices. In addition, it can identify patients
who have complex mental health needs that either need ad-
dressing before surgery or require close observation and pos-
sibly intervention if persisting after surgery [71]. Nonetheless,
to perform the above-mentioned care, 12–24 months of med-
ical weight management prior to surgical referral may not be
required in most patients, and such duration is not supported
by evidence. The current structure of tier 3 is overly rigid with
little flexibility to allow a patient-centred approach to be used
to meet individualized patient needs. For example, patients
who develop post-surgical complex nutritional deficiencies,
mental health disorders, difficult to treat metabolic complica-
tions such as hypoglycaemia, type 2 diabetes recurrence or
weight regain would benefit from access to the tier 3 MDT
expertise, but currently tier 3 services do not routinely provide
input for patients after surgery [71, 72]. Furthermore, there is
currently no data about how to support patients who are
discharged from tier 3 back to primary care due to lack of
meaningful weight loss, although this could change with the
availability of better weight loss pharmacotherapy.
The delivery of integrated weight management pathways
faces several challenges. The list below, while not exhaustive,
presents some of the main challenges:
1. Access to treatment: The provision of the integrated path-
ways is not universal, and there is a “postcode lottery” in
terms of what is delivered at a regional and local level. In
the recent national weight management, mapping exercise
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geographical coverage of tier 2 was 63%, but the coverage
of tier 3 was not possible to identify due the poor response
rate from the clinical commissioning groups (CCGs)
(18%) [7]. A survey of consultant endocrinologists in
2015 showed an estimated coverage of tier 3 of 60%
though more formal mapping was not available (J Wass
& K Knight, RCP internal communication). As for bar-
iatric surgery provision, this is very limited in the UKwith
latest estimates suggest less than 0.002% of the potentially
eligible adults have surgery annually [73]. In addition,
there are many barriers for referral from primary care to
tiers 3 and 4 services even when present, including lack of
clear referral criteria, lack of awareness of the services
available and their clinical outcomes and funding con-
straints from the commissioners [74, 75] resulting in only
a median (IQR) 3 [1–7]% of patients with BMI ≥ 25 kg/
m2 referred for weight management intervention in the
UK [76]. This lack of service commissioning and referral
to specialist services could be in part due to obesity
stigma.
2. Overall structure: The current tiered system lacks flexibil-
ity. While it might have been designed to deliver different
levels of care depending on patient needs, the tiers have
become hurdles rather than one continuum. There is a
need to have flexibility with patients moving through
the tiers depending on their clinical needs and response
to treatment. There is also rigidity in the tiered system that
makes it difficult to cater for patients’ individual needs;
for example, patients who require rapid weight loss to get
another procedure (e.g. hip operation) who may end up
waiting for prolonged periods of time to access services
and may or may not achieve the target weight loss to
allow their procedure to be performed. In addition, many
patients who would require more intensive input in tiers 3
or 4 end up accessing tier 2 first as a pre-condition to
progress in the treatment pathway. All that results in fur-
ther delay and potentially could set up the individual for
multiple cycles of “failed” weight loss attempts which
have significant negative impact.
3. Type of patients seen: Although Tier 3 weight manage-
ment services are supposed to see patients with obesity-
related complications, the available data suggest that most
patients in tier 3 are free of such complications [35]. This
raises a question about how to make sure that the service
is accessible to those with greatest clinical need. It appears
that the criteria used currently may disadvantage patients
with lower BMIs, but established obesity-related compli-
cations, who may have significant clinical benefit from
weight loss.
4. Lack of long-term outcomes and national registry: Unlike
bariatric surgery that has the National Bariatric Surgery
Register (NBSR), tier 3 services currently do not have a
register. This is complicated further by a lack of an agreed
core outcome set to measure in tier 3. However, a recently
published study identified core outcomes set for tier 2
services [77]. Many of the contributors to this study also
work in tier 3, and many of the outcomes identified in this
paper are very reasonable outcomes for a tier 3 service.
Recording the same outcomes at a national level for tier 3
would help provide outcome data, including for cost-
effectiveness analysis, and potentially identify improved
ways to deliver services by learning from those services
that are achieving better outcomes.
5. Bariatric surgery and new treatment modalities: Several
new pharmacotherapies with significant weight loss (>
10–20%) are in development, and many patients with
obesity will be eligible for these medications. However,
currently how Tier 3 services can deliver such treatment,
how they will be funded, the eligibility criteria and the
treatment duration are not clear. In addition, the delivery
formula of low energy diets in primary care as per NHS
long-term plan [78] remains unclear and currently is being
piloted by NHS England [79]. Endoscopic bariatric sur-
gery also is increasingly performed in the private sector
but is not widely available in the NHS as yet. In addition,
and as described above, only a tiny fraction of people
eligible for surgery are able to access it due to multiple
factors including lack of funding.
6. High prevalence of obesity: The adult prevalence of obe-
sity and overweight is 64% and for obesity alone (defined
as BMI ≥ 30 kg/m2) 29% [80]. This Health Survey for
England (HSE) data highlighted the increasing prevalence
of obesity over the years (1997 18%; 2007 25%; 2017
29%). Obviously, we do not know the exact number of
people with obesity who would like to seek weight man-
agement services; but it is likely that this number is sub-
stantive considering the high prevalence of obesity-
related comorbidities and complications. The recent esti-
mates of those who would be eligible for bariatric surgery
in England is 3.6 million adults based on applying NICE
criteria [12] to HSE 2014 data [73]. Such high demand
across all tiers of weight management services is likely to
outweigh the capacity of the current integrated pathway,
even considering tier 2, which has the largest capacity. In
addition, as discussed above, a large proportion of regions
do not have access to either tier 2 or tier 3 services.
7. Referral criteria: The current referral criteria to tier 3
weight management services are largely aligned with
NICE guidelines regarding referral for bariatric surgery
(i.e. BMI ≥ 35 kg/m2 with complications or ≥ 40 kg/m2
without complications). These criteria deprive many pa-
tients who could benefit from tier 3 services from access
to the multidisciplinary team and do not take into account
individual biological factors such as insulin resistance or
beta cell function. Several trials showed that 5–10%
weight loss has a favourable impact in patients with
Curr Obes Rep
obesity-related complications such as pre-diabetes, type 2
diabetes, non-alcoholic fatty liver disease and obstructive
sleep apnoea even with a BMI below 35 and in many
cases below 30. These patients currently do not have ac-
cess to tier 3 services.
8. Obesity stigma: It is increasingly recognized that obesity
stigma is very common within the healthcare system and
is a barrier to healthcare delivery [81, 82]. In 2018, the UK
All-Party Parliamentary Group on Obesity reported that
only 26% of people with obesity reported being treated
with dignity and respect by healthcare professionals when
seeking advice or treatment for their obesity, while 42%
did not feel comfortable talking to their GP about their
obesity [83]. Even experts currently working in obesity
demonstrate stigmatizing beliefs [84, 85]. Weight stigma,
both external and internal, is harmful to an individual’s
psychological health, experiences of healthcare and long-
term physical health [86, 87]. Stigma may in part be due
to the lack of understanding of the biological causes that
drive excess weight amongst healthcare professionals,
decision-makers and the public [88]. Hence, there is a
need to combat obesity stigma both within and outside
the healthcare system. This will require concrete action
from policy-makers, improve obesity education in under-
graduate curriculums and educate healthcare profes-
sionals about obesity and how to avoid stigma. In an at-
tempt to address the latest point, a consensus statement
from multiple obesity experts and patients from the UK
was issued [89].
Some of these challenges are addressed in the BOMSS and
multi-collegiate commissioning guidelines for complex obesity
services [90, 91]. These guidelines provide a detailed framework
towhat should be delivered by primary care and specialist weight
management services, the multidisciplinary team structure and
quality standards to assess performance. These guidelines still
face some challenges including the increased workload of prima-
ry care physicians and the training requirements. In addition,
increased funding is likely to be required to implement these
guidelines, but this could prove challenging due to the lack of
clear cost-effectiveness of the current tier 3 services.
Conclusions
The integrated tiered weight management pathway was devel-
oped in response to the increasing prevalence of obesity in the
UK. Tier 1 public health interventions have failed to date to
effectively prevent the increasing prevalence of obesity. Tiers
2, 3 and 4 are not available universally across England, and
only a fraction of patients who are eligible for these Tiers are
referred and seen. Tier 4 (bariatric surgery) is only performed
on a very small percentage of patients who are eligible. Tiers 2
and 3 result in modest weight loss. However, their impact on
obesity complications is not well studied, and there is a lack of
long-term data. Both tiers 2 and 3 suffer from high dropout
rates. Tier 3, which is tasked with selecting patients for bar-
iatric surgery, is unable to do this with a high degree of accu-
racy due to the lack of data available to guide this process. The
criteria currently used such as achieving 5–10% weight loss
are not evidence based and as such may result in tier 3 being a
hurdle to overcome, rather than a facilitator, for bariatric sur-
gery. The current tier 3 system is also rigid and lacks the
flexibility to adapt to patient needs. However, as commission-
ing tier 3 has recently moved to clinical commissioning
groups, there is now an opportunity to develop more flexible
Fig. 2 The proposed new weight
management system by the
authors. VLED very low energy
diets. The treatment and
prevention tier should be
delivered simultaneously and in
parallel. In the treatment tier, the
most suited intervention for the
patient needs should be delivered
rather than a compulsory step-
wise approach. The
multidisciplinary team will need
to include (but not limited to)
clinicians, surgeons, dietitians,
physical activity specialists,
nurses, appropriate administrative
support for the service and data
collection for evaluation, and
links to all the relevant services in
people with obesity (e.g. sleep
and liver services)
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pathways and move from the previous 12–24 months prior to
surgical referral model to one that can deliver the care needed
to patients in order to reach bariatric surgery as well as offer
support for some patients post bariatric surgery as needed.
One possible way to address this lack of flexibility is to have
a more integrated but simpler and flexible approach to weight
management consistent of two tiers (Fig. 2): a tier for preven-
tion and a tier for treatment. The treatment tier will be flexible
to deliver what suits patients’ needs best, and it encompasses
the current tiers 2, 3 and 4 allowing easy access to the neces-
sary expertise and a range of treatment option for people with
obesity and allowing more involvement of the multidisciplin-
ary team post-bariatric surgery (Fig. 2). Finally, there is a need
to train healthcare professionals and address the stigma within
the healthcare system.
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